8U89 image
Entry Detail
PDB ID:
8U89
EMDB ID:
Keywords:
Title:
The structure of the PP2A-B56Delta holoenzyme mutant - E197K
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-09-16
Release Date:
2024-01-10
Method Details:
Experimental Method:
Resolution:
3.30 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform
Chain IDs:A
Chain Length:589
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform
Mutations:E197K
Chain IDs:B
Chain Length:602
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
Chain IDs:C
Chain Length:309
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
B56 delta long-disordered arms form a dynamic PP2A regulation interface coupled with global allostery and Jordan's syndrome mutations.
Proc.Natl.Acad.Sci.USA 121 e2310727120 e2310727120 (2024)
PMID: 38150499 DOI: 10.1073/pnas.2310727120

Abstact

Intrinsically disordered regions (IDR) and short linear motifs (SLiMs) play pivotal roles in the intricate signaling networks governed by phosphatases and kinases. B56δ (encoded by PPP2R5D) is a regulatory subunit of protein phosphatase 2A (PP2A) with long IDRs that harbor a substrate-mimicking SLiM and multiple phosphorylation sites. De novo missense mutations in PPP2R5D cause intellectual disabilities (ID), macrocephaly, Parkinsonism, and a broad range of neurological symptoms. Our single-particle cryo-EM structures of the PP2A-B56δ holoenzyme reveal that the long, disordered arms at the B56δ termini fold against each other and the holoenzyme core. This architecture suppresses both the phosphatase active site and the substrate-binding protein groove, thereby stabilizing the enzyme in a closed latent form with dual autoinhibition. The resulting interface spans over 190 Å and harbors unfavorable contacts, activation phosphorylation sites, and nearly all residues with ID-associated mutations. Our studies suggest that this dynamic interface is coupled to an allosteric network responsive to phosphorylation and altered globally by mutations. Furthermore, we found that ID mutations increase the holoenzyme activity and perturb the phosphorylation rates, and the severe variants significantly increase the mitotic duration and error rates compared to the normal variant.

Legend

Protein

Chemical

Disease

Primary Citation of related structures